Sun Pharma Launches New Ad Campaign to Raise Awareness of Acne and its Impact on Everyday Life
Sun Pharma
PR-M02-20-NI-024Feb 18, 2020
Drug Development
ILUMYA™ (tildrakizumab-asmn) 3-Year Data Demonstrates Sustained Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis
Sun Pharma
PR-M03-19-NI-002Mar 01, 2019
Sun Pharma Announces USFDA Approval of YONSA® (abiraterone acetate) To Treat Metastatic Castration-Resistant Prostate Cancer In Combination With Methylprednisolone
Sun Pharma
PR-M05-18-NI-098May 25, 2018